Introduction
Cette page fournit une analyse complète de l'historique des opérations d'initiés connues de Kevin F Mclaughlin. Les initiés sont des dirigeants, des administrateurs ou des investisseurs importants dans une entreprise. Il est illégal pour les initiés d'effectuer des opérations d'initiés dans leur entreprise sur la base d'informations spécifiques et non publiques. Cela ne signifie pas qu'il est illégal pour eux d'effectuer toute transaction dans leur propre entreprise. Toutefois, ils doivent déclarer toutes les opérations à la SEC au moyen d'un formulaire 4. Malgré ces restrictions, les recherches universitaires indiquent que les initiés, en général, ont tendance à surperformer le marché dans leurs propres entreprises.
Rentabilité moyenne des opérations
La rentabilité moyenne des opérations est le rendement moyen de tous les achats effectués par l'initié sur le marché public au cours des trois dernières années. Pour ce faire, nous examinons tous les achats non planifiés effectués par l'initié sur le marché public, à l'exclusion de toutes les opérations d'initiés effectuées dans le cadre d'un plan de négociation 10b5-1. Nous calculons ensuite la performance moyenne de ces transactions sur 3, 6 et 12 mois, en faisant la moyenne de chacune de ces durées pour générer un indicateur de performance final pour chaque opération. Enfin, nous faisons la moyenne de tous les indicateurs de performance pour calculer un indicateur de performance pour l'initié. Cette liste ne comprend que les initiés ayant effectué au moins trois opérations d'initiés au cours des deux dernières années.
Si la rentabilité des opérations de cet initié est "N/A", cela signifie qu'il n'a pas effectué d'opérations d'achat sur le marché public au cours des trois dernières années, ou que les opérations qu'il a effectuées sont trop récentes pour permettre le calcul d'un indicateur de performance fiable.
Fréquence de mise à jour : Quotidienne
Entreprises ayant déclaré des positions d'initiés
Les dépôts de la SEC indiquent que Kevin F Mclaughlin a déclaré des participations ou des opérations dans les entreprises suivantes :
Titre | Fonction | Dernières positions déclarées |
---|---|---|
US:VCEL / Vericel Corporation | Director | 15 100 |
US:DBTX / Decibel Therapeutics Inc | Director | 0 |
US:XLRN / Acceleron Pharma Inc | SVP, CFO and Treasurer | 0 |
Comment interpréter les graphiques
Les graphiques suivants montrent la performance des titres après chaque opération non planifiée effectuée par Kevin F Mclaughlin sur le marché public. Les opérations non planifiées sont des opérations qui n'ont pas été effectuées dans le cadre d'un plan de négociation 10b5-1. La performance des actions est représentée sous la forme d'une variation cumulée en pourcentage du cours de l'action. Par exemple, si une opération d'initié a été effectuée le 1er janvier 2019, le graphique montrera la variation quotidienne en pourcentage du titre jusqu'à aujourd'hui. Si le prix de l'action passait de 10 à 15 dollars pendant cette période, la variation cumulée en pourcentage du prix de l'action serait de 50 %. Une variation du cours de 10 à 20 dollars serait de 100 %, et une variation du cours de 10 à 5 dollars serait de -50 %.
Enfin, nous essayons de déterminer dans quelle mesure les opérations d'un initié sont en corrélation avec les rendements excédentaires (positifs ou négatifs) du cours de l'action, afin de déterminer si l'initié synchronise ses opérations pour tirer profit d'informations d'initié. Imaginons qu'un initié agisse de la sorte. Dans ce cas, nous nous attendrions soit (a) à des rendements positifs après les achats, soit (b) à des rendements négatifs après les ventes. Dans le cas (a), le graphique des ACHAT montrerait une série de courbes ascendantes, indiquant des rendements positifs après chaque transaction d'achat. Dans le cas (b), le graphique VENTE montre une série de courbes inclinées vers le bas, indiquant des rendements négatifs après chaque transaction de vente.
Toutefois, cela ne suffit pas pour tirer des conclusions. Si, par exemple, le cours de l'action de l'entreprise a connu une hausse non cyclique pendant de nombreuses années, nous nous attendrions à ce que tous les graphiques postérieurs à l'achat soient en pente ascendante. De même, des baisses non cycliques sur de nombreuses années se traduiraient par des graphiques post-achat en pente descendante. Aucun de ces graphiques ne suggère l'existence d'opérations d'initiés.
L'indicateur le plus fort serait une situation dans laquelle le prix de l'action serait extrêmement cyclique et où il y aurait à la fois des signaux positifs dans le graphique ACHAT et des courbes négatives dans le graphique VENTE. Cette situation suggère fortement la présence d'un initié qui planifie les opérations d'initiés de manière à en tirer un avantage financier.
Achats d'initiés VCEL / Vericel Corporation - Analyse des bénéfices à court terme
Dans cette section, nous analysons la rentabilité de chaque achat d'initié non planifié et effectué sur le marché public dans VCEL / Vericel Corporation. Cette analyse permet de comprendre si l'initié génère régulièrement des rendements anormaux et s'il vaut la peine d'être suivi. Cette analyse porte sur l'année qui suit chaque opération, tout en sachant que les résultats sont théoriques.
Le tableau suivant présente les achats les plus récents sur le marché public qui ne faisaient pas partie d'un plan de trading automatique.
Date de l'opération | Libellé | Initié | Actions déclarées |
Prix déclaré |
Actions ajustées |
Prix ajusté |
Coût de base | Jours jusqu'à Max |
Prix à Max |
Bénéfice Max ($) |
Rendement maximal (%) |
---|---|---|---|---|---|---|---|
Il n'y a pas d'opérations d'initiés non planifiées connues sur le marché public pour cette combinaison d'initiés et de titres. |
Prix ajusté est le prix ajusté après fractionnement. Actions ajustées est le nombre d'actions ajustées après fractionnement.
Ventes d'initiés VCEL / Vericel Corporation - Analyse des pertes à court terme
Dans cette section, nous analysons la capacité à éviter les pertes à court terme lors de chaque vente d'initié non planifiée et réalisée sur le marché public dans VCEL / Vericel Corporation. Un modèle régulier d'évitement des pertes peut suggérer que les transactions de vente futures peuvent prédire des baisses de prix. Cette analyse porte sur un an après chaque opération, tout en sachant que les résultats sont théoriques.
Le tableau suivant présente les dernières opérations sur le marché public qui ne faisaient pas partie d'un plan de trading automatique.
Date de l'opération | Libellé | Initié | Actions déclarées |
Prix déclaré |
Actions ajustées |
Prix ajusté |
Coût de base | Jours jusqu'à Min |
Prix à Min |
Perte maximale évitée ($) |
Perte maximale évitée (%) |
---|---|---|---|---|---|---|---|
Il n'y a pas d'opérations d'initiés non planifiées connues sur le marché public pour cette combinaison d'initiés et de titres. |
Prix ajusté est le prix ajusté après fractionnement. Actions ajustées est le nombre d'actions ajustées après fractionnement.
Historique des opérations d'initiés
Ce tableau présente la liste complète des opérations d'initiés effectuées par Kevin F Mclaughlin, telles que divulguées à la Securities Exchange Commission (SEC).
Date de dépôt | Date de l'opération | Formulaire | Libellé | Titre | Code | Actions | Actions restantes | Pourcentage de variation |
Prix de l'action |
Valeur de l'opération |
Valeur restante |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-08-08 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | -7 000 | 15 100 | -31,67 | 35,92 | -251 440 | 542 392 |
2025-08-08 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 7 000 | 22 100 | 46,36 | 2,76 | 19 320 | 60 996 | |
2025-05-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | -7 000 | 15 100 | -31,67 | 39,98 | -279 860 | 603 698 |
2025-05-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 7 000 | 22 100 | 46,36 | 2,76 | 19 320 | 60 996 | |
2025-05-02 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 3 200 | 15 100 | 26,89 | ||||
2025-02-14 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | -1 000 | 11 900 | -7,75 | 55,43 | -55 430 | 659 617 |
2025-02-14 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 1 000 | 12 900 | 8,40 | 2,76 | 2 760 | 35 604 | |
2025-02-14 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | -6 000 | 11 900 | -33,52 | 55,47 | -332 820 | 660 093 |
2025-02-14 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 6 000 | 17 900 | 50,42 | 3,74 | 22 440 | 66 946 | |
2024-11-15 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | -7 000 | 11 900 | -37,04 | 55,54 | -388 780 | 660 926 |
2024-11-15 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 7 000 | 18 900 | 58,82 | 3,74 | 26 180 | 70 686 | |
2024-08-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | -2 000 | 11 900 | -14,39 | 45,99 | -91 980 | 547 281 |
2024-08-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 2 000 | 13 900 | 16,81 | 3,74 | 7 480 | 51 986 | |
2024-08-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | -5 000 | 11 900 | -29,59 | 45,92 | -229 600 | 546 448 |
2024-08-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 5 000 | 16 900 | 42,02 | 3,74 | 18 700 | 63 206 | |
2024-05-03 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 3 200 | 11 900 | 36,78 | ||||
2023-09-25 |
|
4 | DBTX |
Decibel Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -5 000 | 0 | -100,00 | ||||
2023-06-14 |
|
4 | DBTX |
Decibel Therapeutics, Inc.
Common Stock |
A - Award | 5 000 | 5 000 | |||||
2023-04-28 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 2 600 | 8 700 | 42,62 | ||||
2022-04-29 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
A - Award | 2 600 | 2 600 | |||||
2022-04-29 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 6 500 | 6 500 | |||||
2022-04-29 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
M - Exercise | -2 600 | 0 | -100,00 | ||||
2022-04-29 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 2 600 | 6 100 | 74,29 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | -18 806 | 0 | -100,00 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | -24 334 | 0 | -100,00 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | -20 500 | 0 | -100,00 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | -11 262 | 0 | -100,00 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | -2 663 | 0 | -100,00 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
U - Other | -10 681 | 0 | -100,00 | ||||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -170 | 20 500 | -0,82 | |||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 200 | 11 262 | -31,59 | |||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -5 370 | 10 681 | -33,46 | 160,38 | -861 241 | 1 713 019 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 170 | 16 051 | 1,07 | 41,64 | 7 079 | 668 364 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 200 | 15 881 | 48,68 | 40,61 | 211 172 | 644 927 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -7 330 | 20 670 | -26,18 | |||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -9 800 | 16 462 | -37,32 | |||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 500 | 2 663 | -48,42 | |||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -983 | 10 681 | -8,43 | 161,26 | -158 519 | 1 722 418 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -18 647 | 11 664 | -61,52 | 160,26 | -2 988 368 | 1 869 273 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 330 | 30 311 | 31,90 | 41,64 | 305 221 | 1 262 150 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 9 800 | 22 981 | 74,35 | 40,61 | 397 978 | 933 258 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 500 | 13 181 | 23,41 | 30,17 | 75 425 | 397 671 |
2021-04-30 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
A - Award | 2 600 | 2 600 | |||||
2021-04-30 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 6 500 | 6 500 | |||||
2021-04-30 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
M - Exercise | -1 750 | 0 | -100,00 | ||||
2021-04-30 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 1 750 | 3 500 | 100,00 | ||||
2021-02-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 18 806 | 18 806 | |||||
2021-02-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 4 868 | 10 681 | 83,74 | ||||
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 | 5 813 | -0,07 | 123,50 | -494 | 717 906 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -296 | 5 817 | -4,84 | 122,85 | -36 364 | 714 618 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -499 | 6 113 | -7,55 | 121,89 | -60 823 | 745 114 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -700 | 6 612 | -9,57 | 120,43 | -84 301 | 796 283 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -300 | 7 312 | -3,94 | 124,45 | -37 335 | 909 978 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -667 | 7 612 | -8,06 | 124,47 | -83 021 | 947 466 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -600 | 8 279 | -6,76 | 123,49 | -74 094 | 1 022 374 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -200 | 8 879 | -2,20 | 125,49 | -25 098 | 1 114 226 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -713 | 9 079 | -7,28 | 124,28 | -88 612 | 1 128 338 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -800 | 9 792 | -7,55 | 123,54 | -98 832 | 1 209 704 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
F - Taxes | -624 | 10 592 | -5,56 | 124,31 | -77 569 | 1 316 692 | |
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 590 | 26 262 | -8,98 | |||
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -24 986 | 5 163 | -82,88 | |||
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -7 700 | 0 | -100,00 | |||
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -7 252 | 0 | -100,00 | |||
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -42 528 | 11 216 | -79,13 | 130,14 | -5 534 594 | 1 459 650 |
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 590 | 53 744 | 5,06 | 40,61 | 105 180 | 2 182 544 |
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 24 986 | 51 154 | 95,48 | 30,17 | 753 828 | 1 543 316 |
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 700 | 26 168 | 41,69 | 27,97 | 215 369 | 731 919 |
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 252 | 18 468 | 64,66 | 41,20 | 298 782 | 760 882 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 100 | 7 252 | -29,95 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 100 | 11 216 | -21,65 | 125,00 | -387 500 | 1 402 000 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 100 | 14 316 | 27,64 | 41,20 | 127 720 | 589 819 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -100 | 28 852 | -0,35 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -100 | 28 852 | -0,35 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -100 | 30 149 | -0,33 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -200 | 7 700 | -2,53 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -500 | 11 216 | -4,27 | 125,12 | -62 560 | 1 403 346 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 100 | 11 716 | 0,86 | 40,61 | 4 061 | 475 787 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 100 | 11 616 | 0,87 | 30,17 | 3 017 | 350 455 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 200 | 11 516 | 1,77 | 27,97 | 5 594 | 322 103 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 100 | 11 316 | 0,89 | 41,20 | 4 120 | 466 219 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 873 | 28 952 | -6,08 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 051 | 30 249 | -3,36 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -400 | 7 900 | -4,82 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -548 | 10 452 | -4,98 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 872 | 11 216 | -25,66 | 125,03 | -484 116 | 1 402 336 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 873 | 15 088 | 14,17 | 40,61 | 76 063 | 612 724 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 051 | 13 215 | 8,64 | 30,17 | 31 709 | 398 697 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 400 | 12 164 | 3,40 | 27,97 | 11 188 | 340 227 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 548 | 11 764 | 4,89 | 41,20 | 22 578 | 484 677 |
2020-05-01 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
A - Award | 1 750 | 1 750 | |||||
2020-05-01 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 13 125 | 13 125 | |||||
2020-05-01 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
M - Exercise | -1 750 | 0 | -100,00 | 14,56 | -25 480 | ||
2020-05-01 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 1 750 | 1 750 | |||||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -17 226 | 11 000 | -61,03 | |||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -17 226 | 11 216 | -60,57 | 88,19 | -1 519 161 | 989 139 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 17 226 | 28 442 | 153,58 | 41,20 | 709 711 | 1 171 810 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -10 000 | 31 300 | -24,21 | |||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -10 000 | 31 300 | -24,21 | |||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -12 774 | 28 226 | -31,16 | |||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -4 000 | 0 | -100,00 | |||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 703 | 11 216 | -24,82 | 87,50 | -324 012 | 981 400 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -5 921 | 14 919 | -28,41 | 86,79 | -513 884 | 1 294 820 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -15 410 | 20 840 | -42,51 | 85,80 | -1 322 178 | 1 788 072 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 803 | 36 250 | -9,49 | 84,89 | -322 837 | 3 077 262 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -5 037 | 40 053 | -11,17 | 83,68 | -421 496 | 3 351 635 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 900 | 45 090 | -6,04 | 82,83 | -240 207 | 3 734 805 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 47 990 | 26,32 | 30,17 | 301 700 | 1 447 858 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 37 990 | 35,73 | 27,97 | 279 700 | 1 062 580 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 12 774 | 27 990 | 83,95 | 41,20 | 526 289 | 1 153 188 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 15 216 | 35,66 | 24,11 | 96 440 | 366 858 |
2020-01-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 24 334 | 24 334 | |||||
2020-01-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 6 369 | 11 216 | 131,40 | ||||
2020-01-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 566 | 4 847 | -24,42 | 52,52 | -82 246 | 254 564 |
2020-01-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 300 | 6 413 | -26,40 | 52,49 | -120 727 | 336 618 |
2020-01-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 713 | 8 713 | -16,43 | 52,51 | -89 950 | 457 520 |
2019-12-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -11 853 | 10 426 | -53,20 | 50,28 | -595 969 | 524 219 |
2019-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -173 | 22 279 | -0,77 | 45,75 | -7 915 | 1 019 264 |
2019-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -7 827 | 22 452 | -25,85 | 45,29 | -354 485 | 1 016 851 |
2019-05-03 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
A - Award | 1 750 | 1 750 | |||||
2019-05-03 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 13 125 | 13 125 | |||||
2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 30 279 | -0,33 | 45,46 | -4 546 | 1 376 483 |
2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -11 900 | 30 379 | -28,15 | 44,61 | -530 859 | 1 355 207 |
2019-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -648 | 42 279 | -1,51 | 48,02 | -31 117 | 2 030 238 |
2019-01-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 28 000 | 28 000 | |||||
2019-01-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 4 700 | 42 927 | 12,29 | ||||
2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -97 | 38 227 | -0,25 | 44,06 | -4 274 | 1 684 282 |
2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 717 | 38 324 | -4,29 | 43,33 | -74 398 | 1 660 579 |
2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 186 | 40 041 | -5,18 | 42,56 | -93 036 | 1 704 145 |
2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -300 | 42 227 | -0,71 | 43,20 | -12 960 | 1 824 206 |
2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 412 | 42 527 | -3,21 | 42,37 | -59 826 | 1 801 869 |
2018-08-31 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -12 500 | 18 300 | -40,58 | |||
2018-08-31 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -12 500 | 43 939 | -22,15 | 54,00 | -675 000 | 2 372 706 |
2018-08-31 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 12 500 | 56 439 | 28,45 | 27,97 | 349 625 | 1 578 599 |
2018-07-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -25 000 | 4 000 | -86,21 | |||
2018-07-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -12 500 | 43 939 | -22,15 | 49,00 | -612 500 | 2 153 011 |
2018-07-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -12 500 | 56 439 | -18,13 | 47,00 | -587 500 | 2 652 633 |
2018-07-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 25 000 | 68 939 | 56,90 | 24,11 | 602 750 | 1 662 119 |
2018-05-03 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -800 | 43 939 | -1,79 | 39,00 | -31 200 | 1 713 621 |
2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 200 | 44 739 | -6,68 | 38,31 | -122 592 | 1 713 951 |
2018-03-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 30 825 | 30 825 | |||||
2018-03-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 5 138 | 47 939 | 12,00 | ||||
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -200 | 42 801 | -0,47 | 43,84 | -8 768 | 1 876 396 |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -14 800 | 43 001 | -25,61 | 43,00 | -636 400 | 1 849 043 |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -6 250 | 0 | -100,00 | ||||
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -6 251 | 0 | -100,00 | ||||
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 6 250 | 57 801 | 12,12 | 5,28 | 33 000 | 305 189 | |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 6 251 | 51 551 | 13,80 | 3,88 | 24 254 | 200 018 | |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 000 | 45 300 | -8,11 | 42,42 | -169 680 | 1 921 626 |
2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -210 | 49 300 | -0,42 | 39,85 | -8 368 | 1 964 605 |
2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 300 | 49 510 | -2,56 | 39,17 | -50 921 | 1 939 307 |
2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -14 490 | 50 810 | -22,19 | 38,32 | -555 257 | 1 947 039 |
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -18 750 | 0 | -100,00 | |||
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 150 | 6 250 | -33,51 | |||
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -34 400 | 65 300 | -34,50 | 32,00 | -1 100 800 | 2 089 600 |
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 18 750 | 99 700 | 23,16 | 7,12 | 133 500 | 709 864 |
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 150 | 80 950 | 4,05 | 5,28 | 16 632 | 427 416 |
2017-05-05 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 41 300 | 41 300 | |||||
2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 6 900 | 77 800 | 9,73 | ||||
2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 300 | 70 900 | -1,80 | 27,63 | -35 919 | 1 958 967 |
2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -400 | 72 200 | -0,55 | 26,87 | -10 748 | 1 940 014 |
2017-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -10 000 | 6 251 | -61,53 | ||||
2017-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 10 000 | 72 600 | 15,97 | 3,88 | 38 800 | 281 688 | |
2016-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -5 000 | 16 251 | -23,53 | ||||
2016-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 62 600 | 8,68 | 3,88 | 19 400 | 242 888 | |
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -15 300 | 9 400 | -61,94 | |||
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -25 300 | 57 600 | -30,52 | 34,66 | -876 898 | 1 996 416 |
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 15 300 | 82 900 | 22,63 | 5,28 | 80 784 | 437 712 |
2016-05-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -300 | 24 700 | -1,20 | |||
2016-05-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -25 300 | 67 600 | -27,23 | 34,00 | -860 200 | 2 298 400 |
2016-05-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 300 | 92 900 | 0,32 | 5,28 | 1 584 | 490 512 |
2016-05-06 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 30 800 | 30 800 | |||||
2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 5 100 | 92 600 | 5,83 | ||||
2015-12-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -7 500 | 21 251 | -26,09 | ||||
2015-12-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 7 500 | 87 500 | 9,38 | 3,88 | 29 100 | 339 500 | |
2015-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -7 000 | 28 751 | -19,58 | |||
2015-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 460 | 80 000 | -4,15 | 24,64 | -85 254 | 1 971 200 |
2015-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 540 | 83 460 | -4,07 | 24,12 | -85 385 | 2 013 055 |
2015-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 87 000 | 8,75 | 3,88 | 27 160 | 337 560 |
2015-09-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 40 000 | 80 000 | 100,00 | ||||
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 500 | 35 751 | -4,03 | |||
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 000 | 37 251 | -11,83 | |||
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -176 | 40 000 | -0,44 | 31,16 | -5 484 | 1 246 400 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -724 | 40 176 | -1,77 | 30,45 | -22 046 | 1 223 359 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -600 | 40 900 | -1,45 | 29,39 | -17 634 | 1 202 051 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 41 500 | 3,75 | 3,88 | 5 820 | 161 020 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 293 | 40 000 | -3,13 | 31,07 | -40 174 | 1 242 800 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 500 | 41 293 | -5,71 | 30,22 | -75 550 | 1 247 874 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 207 | 43 793 | -2,68 | 29,11 | -35 136 | 1 274 814 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 45 000 | 12,50 | 3,88 | 19 400 | 174 600 |
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 500 | 42 251 | -3,43 | |||
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 000 | 43 751 | -10,26 | |||
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 500 | 40 000 | -3,61 | 28,54 | -42 810 | 1 141 600 |
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 41 500 | 3,75 | 3,88 | 5 820 | 161 020 |
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 40 000 | -0,25 | 29,23 | -2 923 | 1 169 200 |
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 900 | 40 100 | -10,89 | 28,51 | -139 699 | 1 143 251 |
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 45 000 | 12,50 | 3,88 | 19 400 | 174 600 |
2015-07-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -5 000 | 48 751 | -9,30 | ||||
2015-07-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 40 000 | 14,29 | 3,88 | 19 400 | 155 200 | |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 000 | 53 751 | -3,59 | |||
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 000 | 55 751 | -8,23 | |||
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -95 | 35 000 | -0,27 | 30,39 | -2 887 | 1 063 650 |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 905 | 35 095 | -5,15 | 29,68 | -56 540 | 1 041 620 |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 37 000 | 5,71 | 3,88 | 7 760 | 143 560 |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -377 | 35 000 | -1,07 | 30,27 | -11 412 | 1 059 450 |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 623 | 35 377 | -11,56 | 29,65 | -137 072 | 1 048 928 |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 40 000 | 14,29 | 3,88 | 19 400 | 155 200 |
2015-06-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -5 000 | 60 751 | -7,60 | ||||
2015-06-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 35 000 | 16,67 | 3,88 | 19 400 | 135 800 | |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 500 | 65 751 | -2,23 | |||
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 000 | 67 251 | -6,92 | |||
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -200 | 30 000 | -0,66 | 32,96 | -6 592 | 988 800 |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 300 | 30 200 | -4,13 | 32,37 | -42 081 | 977 574 |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 31 500 | 5,00 | 3,88 | 5 820 | 122 220 |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 30 000 | -0,33 | 32,97 | -3 297 | 989 100 |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 900 | 30 100 | -14,00 | 32,49 | -159 201 | 977 949 |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 35 000 | 16,67 | 3,88 | 19 400 | 135 800 |
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -5 000 | 72 251 | -6,47 | ||||
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -6 500 | 77 251 | -7,76 | |||
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 | |
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 500 | 25 000 | -5,66 | 31,78 | -47 670 | 794 500 |
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 26 500 | -0,38 | 32,40 | -3 240 | 858 600 |
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 900 | 26 600 | -15,56 | 31,79 | -155 771 | 845 614 |
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 6 500 | 31 500 | 26,00 | 3,88 | 25 220 | 122 220 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 000 | 83 751 | -5,63 | |||
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 000 | 88 751 | -2,20 | |||
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -500 | 25 000 | -1,96 | 35,50 | -17 750 | 887 500 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 500 | 25 500 | -15,00 | 34,80 | -156 600 | 887 400 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -250 | 25 000 | -0,99 | 35,52 | -8 880 | 888 000 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 750 | 25 250 | -6,48 | 34,82 | -60 935 | 879 205 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 27 000 | 8,00 | 3,88 | 7 760 | 104 760 |
2015-03-24 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 500 | 90 751 | -1,63 | |||
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 000 | 92 251 | -5,14 | |||
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -200 | 25 000 | -0,79 | 40,94 | -8 188 | 1 023 500 |
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 300 | 25 200 | -4,91 | 40,14 | -52 182 | 1 011 528 |
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 26 500 | 6,00 | 3,88 | 5 820 | 102 820 |
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -619 | 25 000 | -2,42 | 40,93 | -25 336 | 1 023 250 |
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 381 | 25 619 | -14,60 | 40,16 | -175 941 | 1 028 859 |
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 |
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 500 | 97 251 | -1,52 | |||
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 000 | 98 751 | -4,82 | |||
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 500 | 25 000 | -5,66 | 36,65 | -54 975 | 916 250 |
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 26 500 | 6,00 | 3,88 | 5 820 | 102 820 |
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -400 | 25 000 | -1,57 | 37,11 | -14 844 | 927 750 |
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 600 | 25 400 | -15,33 | 36,60 | -168 360 | 929 640 |
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 |
2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 000 | 103 751 | -1,89 | |||
2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -845 | 25 000 | -3,27 | 41,04 | -34 679 | 1 026 000 |
2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 155 | 25 845 | -4,28 | 40,38 | -46 639 | 1 043 621 |
2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 27 000 | 8,00 | 3,88 | 7 760 | 104 760 |
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 41 000 | 41 000 | |||||
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 000 | 105 751 | -4,51 | |||
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 300 | 25 000 | -14,68 | 39,59 | -170 237 | 989 750 |
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -700 | 29 300 | -2,33 | 38,67 | -27 069 | 1 133 031 |
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 |
2015-01-07 | 3 | VCEL |
Vericel Corp
No securities are beneficially owned |
0 | ||||||||
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -15 000 | 110 751 | -11,93 | ||||
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 15 000 | 25 000 | 150,00 | 3,88 | 58 200 | 97 000 | |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -10 000 | 125 751 | -7,37 | |||
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 10 000 | -0,99 | 47,64 | -4 764 | 476 400 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -200 | 10 100 | -1,94 | 46,76 | -9 352 | 472 276 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -300 | 10 300 | -2,83 | 45,79 | -13 737 | 471 637 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 600 | 10 600 | -13,11 | 44,84 | -71 744 | 475 304 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 100 | 12 200 | -8,27 | 44,21 | -48 631 | 539 362 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 300 | 13 300 | -8,90 | 42,86 | -55 718 | 570 038 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -200 | 14 600 | -1,35 | 41,18 | -8 236 | 601 228 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -200 | 14 800 | -1,33 | 39,52 | -7 904 | 584 896 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -196 | 15 000 | -1,29 | 47,23 | -9 257 | 708 450 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -300 | 15 196 | -1,94 | 46,39 | -13 917 | 704 942 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 000 | 15 496 | -6,06 | 45,17 | -45 170 | 699 954 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 759 | 16 496 | -9,64 | 44,34 | -77 994 | 731 433 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 344 | 18 255 | -6,86 | 42,96 | -57 738 | 784 235 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 19 599 | -0,51 | 41,14 | -4 114 | 806 303 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -201 | 19 699 | -1,01 | 40,34 | -8 108 | 794 658 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 19 900 | -0,50 | 38,52 | -3 852 | 766 548 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 3,88 | 38 800 | 77 600 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -10 000 | 135 751 | -6,86 | |||
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 138 | 10 000 | -23,88 | 33,58 | -105 374 | 335 800 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 862 | 13 138 | -12,41 | 32,39 | -60 310 | 425 540 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 050 | 15 000 | -16,90 | 33,60 | -102 480 | 504 000 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 950 | 18 050 | -9,75 | 32,44 | -63 258 | 585 542 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 3,88 | 38 800 | 77 600 |
2014-10-27 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -10 000 | 145 751 | -6,42 | ||||
2014-10-27 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 10 000 | 10 000 | 3,88 | 38 800 | 38 800 | ||
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -10 000 | 155 751 | -6,03 | |||
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -10 000 | 0 | -100,00 | 29,25 | -292 500 | |
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 3,88 | 38 800 | 38 800 | |
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -6 700 | 165 751 | -3,89 | |||
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -370 | 0 | -100,00 | 24,75 | -9 158 | |
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -6 330 | 370 | -94,48 | 24,24 | -153 439 | 8 969 |
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 6 700 | 6 700 | 3,88 | 25 996 | 25 996 | |
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 300 | 172 451 | -1,88 | |||
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 300 | 0 | -100,00 | 24,90 | -82 170 | |
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 300 | 3 300 | 3,88 | 12 804 | 12 804 | |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -7 000 | 175 751 | -3,83 | |||
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 000 | 182 751 | -1,62 | |||
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -7 000 | 0 | -100,00 | 29,79 | -208 530 | |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 000 | 0 | -100,00 | 29,76 | -89 280 | |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 3,88 | 11 640 | 11 640 | |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -7 000 | 185 751 | -3,63 | |||
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 000 | 192 751 | -1,53 | |||
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 800 | 0 | -100,00 | 32,59 | -58 662 | |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -5 200 | 1 800 | -74,29 | 31,42 | -163 384 | 56 556 |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -800 | 0 | -100,00 | 32,56 | -26 048 | |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 200 | 800 | -73,33 | 31,40 | -69 080 | 25 120 |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 3,88 | 11 640 | 11 640 | |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | X | -7 000 | 195 751 | -3,45 | |||
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | X | -3 000 | 202 751 | -1,46 | |||
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 197 | 0 | -100,00 | 31,98 | -134 220 | |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 803 | 4 197 | -40,04 | 31,16 | -87 341 | 130 779 |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 686 | 0 | -100,00 | 32,00 | -53 952 | |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 314 | 1 686 | -43,80 | 31,17 | -40 957 | 52 553 |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 3,88 | 11 640 | 11 640 | |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -7 000 | 205 751 | -3,29 | |||
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 000 | 212 751 | -1,39 | |||
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -286 | 0 | -100,00 | 32,17 | -9 201 | |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -6 714 | 286 | -95,91 | 31,49 | -211 424 | 9 006 |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 0 | -100,00 | 32,27 | -3 227 | |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 900 | 100 | -96,67 | 31,48 | -91 292 | 3 148 |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 3,88 | 11 640 | 11 640 | |
2013-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 29 000 | 29 000 |